German healthcare company Schülke & Mayr has acquired Redditch Medical, a UK-based manufacturer of cleanroom contamination control products. The transaction delivers an exit for investment firm Traditum, which backed a management buy-out of Redditch Medical’s parent company Entaco Group in 2024.
Redditch Medical, founded in 2012, produces the InSpec range of disinfectants and detergents for life sciences and provides technical support through microbiological and chemical analytics. The business employs 44 staff, with exports driving most of its turnover.
Following Traditum’s investment, the business expanded production capacity, opened a laboratory, strengthened its management structure and launched new product lines. This led to growth in both domestic and international markets.
Schülke & Mayr’s purchase gives it a stronger foothold in cleanroom solutions, complementing its infection prevention portfolio across pharmaceutical and biotech sectors. Redditch Medical will continue operations under its current leadership while pursuing further expansion in European and global markets.
Traditum retains a stake in Entaco’s other divisions, which continue to manufacture surgical needles and medical devices in Worcestershire.
David Mitchell, CEO of Traditum, said: “Redditch Medical shows how strong leadership and supportive investors can unlock the potential of a business. Under Steve’s direction and with Traditum’s support, it has undergone a remarkable transformation in a little over a year. Becoming part of schülke will open up new opportunities as it enters the next stage of its growth journey.”
